FindTrial
Sign In

Feasibility study of risk-reducing mastectomy for hereditary breast and ovarian cancer syndrome with BRCA1/2 mutation

Feasibility study of risk-reducing mastectomy for hereditary breast and ovarian cancer syndrome with BRCA1/2 mutation - Feasibility study of risk-reducing mastectomy for BRCA1/2 mutation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031858
Enrollment
15
Registered
2018-04-01
Start date
2018-07-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Breast and Ovarian Cancer Syndrome

Interventions

risk-reducing mastectomy

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women with BRCA1/2 pathogenic mutation who desire risk-reducing mastectomy 2. No clinical evidence of malignancy in the breast 3. ECOG Performance Status 0-1 4. Without major organ disorder 5. Age >=20 6. Understanding that medical expenses of the risk-reducing mastectomy is not covered by insurance 7. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with reccurent or metastatic breast cancer 2. Patients with other factors not eligible for this study

Design outcomes

Primary

MeasureTime frame
Rate of the adverse event during risk-reducing mastectomy—

Countries

Japan

Contacts

Public ContactMasahiro Takada

Kyoto University Hospital Breast Surgery

masahiro@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026